1-5 of 5
Katie Vo
Close
Sort by
Journal Articles

Normalization of cerebral hemodynamics after hematopoietic stem cell transplant in children with sickle cell disease

Clinical Trials & Observations
Monica L. Hulbert, Melanie E. Fields, Kristin P. Guilliams, Priyesha Bijlani, Shalini Shenoy, Slim Fellah, Alison S. Towerman, Michael M. Binkley, Robert C. McKinstry, Joshua S. Shimony, Yasheng Chen, Cihat Eldeniz, Dustin K. Ragan, Katie Vo, Hongyu An, Jin-Moo Lee, Andria L. Ford
Journal: Blood
Blood (2023) 141 (4): 335–344.
https://doi.org/10.1182/blood.2022016618
Published: 2023
Includes: Supplemental data
Journal Articles

Hydroxyurea reduces cerebral metabolic stress in patients with sickle cell anemia

Melanie E. Fields, Kristin P. Guilliams, Dustin Ragan, Michael M. Binkley, Amy Mirro, Slim Fellah, Monica L. Hulbert, Morey Blinder, Cihat Eldeniz, Katie Vo, Joshua S. Shimony, Yasheng Chen, Robert C. McKinstry, Hongyu An, Jin-Moo Lee, Andria L. Ford
Journal: Blood
Blood (2019) 133 (22): 2436–2444.
https://doi.org/10.1182/blood-2018-09-876318
Published: 2019
Journal Articles

Analysis of the Incidence of Treatment-Related Myelodysplastic Syndrome and Acute Myelogenous Leukemia in Registration and Compassionate-Use Trials of Ibritumomab Tiuxetan Radioimmunotherapy (RIT).

Myron S. Czuczman, MD, Christos Emmanouilides, Mohamed Darif, Thomas E. Witzig, Leo I. Gordon, Steven Revell, Katie Vo, Arturo Molina
Journal: Blood
Blood (2006) 108 (11): 485.
https://doi.org/10.1182/blood.V108.11.485.485
Published: 2006
Journal Articles

Yttrium 90 ( 90 Y) Ibritumomab Tiuxetan (Zevalin®) Induces Long-Term Responses in Patients with Relapsed or Refractory Follicular Lymphoma (FL).

Russell J. Schilder, MD, Thomas E. Witzig, MD, Ian Flinn, MD, Leo I. Gordon, MD, Christos Emmanouilides, MD, Hua Wang, MS, Katie Vo, Arturo Molina, MD.
Journal: Blood
Blood (2004) 104 (11): 2629.
https://doi.org/10.1182/blood.V104.11.2629.2629
Published: 2004
Journal Articles

Evaluation of Baseline Body-Weight Dosing of Yttrium 90 ( 90 Y) Ibritumomab Tiuxetan (Zevalin®) Radioimmunotherapy in Patients with Relapsed or Refractory B-Cell Non-Hodgkin’s Lymphoma (NHL).

Gregory Wiseman, MD, Peter Conti, MD, Katie Vo, Russell J. Schilder, MD, Paul Foster, MD, Leo I. Gordon, MD, Christos Emmanouilides, MD, Dan Silverman, MD, Thomas E. Witzig, MD, Arturo Molina, MD
Journal: Blood
Blood (2004) 104 (11): 2634.
https://doi.org/10.1182/blood.V104.11.2634.2634
Published: 2004